Nypozi

Active Ingredient(s): Filgrastim-txid
FDA Approved: * June 28, 2024
Pharm Company: * TANVEX BIOPHARMA USA INC
Category: Cancer

Filgrastim, sold under the brand name Neupogen among others, is a medication used to treat low neutrophil count.[6] Low neutrophil counts may occur with HIV/AIDS, following chemotherapy or radiation poisoning, or be of an unknown cause.[6] It may also be used to increase white blood cells for gathering during leukapheresis.[6] It is given either by injection into a vein or under the skin.[6] Common side effects include fever, cou... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Related Brands

Drugs with the same active ingredients